During the past decade, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Implandata Ophthalmic Products GmbH" with 2 trials sponsored, "Ivantis, Inc." with 1 trials sponsored, "RHEACELL GmbH & Co. KG" with 1 trials sponsored and "University Eye Hospital, Freiburg" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik" #1 collaborator was "CRO Dr. med. Kottmann GmbH & Co. KG" with 2 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator, "Granzer Regulatory Consulting & Services" with 1 trials as a collaborator and "Ticeba GmbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik" are "Glaucoma" (2 trials), "Open Angle Glaucoma" (2 trials), "Diabetic Macular Edema" (1 trials), "Geographic Atrophy" (1 trials) and "Limbal Stem Cell Deficiency" (1 trials). Many other conditions were trialed in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik" in a lesser frequency.

Most popular intervention types in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik" are "Drug" (4 trials), "Device" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARGOS-SC suprachoroidal pressure sensor" (2 trials), "Aflibercept" (1 trials), "Atropine eye drops, 0.01%" (1 trials), "Atropine eye drops, 0.02%" (1 trials) and "Faricimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Augenklinik und Poliklinik, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".